These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Urinary isoflavonoid phytoestrogen and lignan excretion after consumption of fermented and unfermented soy products. Hutchins AM; Slavin JL; Lampe JW J Am Diet Assoc; 1995 May; 95(5):545-51. PubMed ID: 7722188 [TBL] [Abstract][Full Text] [Related]
44. Effects of Glycine max (L.) Merr. soy isoflavone vaginal gel on epithelium morphology and estrogen receptor expression in postmenopausal women: a 12-week, randomized, double-blind, placebo-controlled trial. Lima SM; Bernardo BF; Yamada SS; Reis BF; da Silva GM; Galvão MA Maturitas; 2014 Jul; 78(3):205-11. PubMed ID: 24856055 [TBL] [Abstract][Full Text] [Related]
45. Daidzein and genistein have differential effects in decreasing whole body bone mineral density but had no effect on hip and spine density in premenopausal women: A 2-year randomized, double-blind, placebo-controlled study. Nayeem F; Chen NW; Nagamani M; Anderson KE; Lu LW Nutr Res; 2019 Aug; 68():70-81. PubMed ID: 31421395 [TBL] [Abstract][Full Text] [Related]
46. What is the role of phytoestrogens in treating menopausal symptoms? Murkies AL; Teede HJ; Davis SR Med J Aust; 2000 Nov; 173(S4):S97-8. PubMed ID: 11149376 [TBL] [Abstract][Full Text] [Related]
47. Effects of isoflavones on the coagulation and fibrinolytic system of postmenopausal women. Rios DR; Rodrigues ET; Cardoso AP; Montes MB; Franceschini SA; Toloi MR Nutrition; 2008 Feb; 24(2):120-6. PubMed ID: 18065202 [TBL] [Abstract][Full Text] [Related]
48. The clinical use of a preparation based on phyto-oestrogens in the treatment of menopausal disorders. Russo R; Corosu R Acta Biomed; 2003 Dec; 74(3):137-43. PubMed ID: 15055018 [TBL] [Abstract][Full Text] [Related]
49. Lack of effects of isoflavones on the lipid profile of Brazilian postmenopausal women. Rios DR; Rodrigues ET; Cardoso AP; Montes MB; Franceschini SA; Toloi MR Nutrition; 2008; 24(11-12):1153-8. PubMed ID: 18842392 [TBL] [Abstract][Full Text] [Related]
50. Effects of a soy-based dietary supplement compared with low-dose hormone therapy on the urogenital system: a randomized, double-blind, controlled clinical trial. Carmignani LO; Pedro AO; Montemor EB; Arias VA; Costa-Paiva LH; Pinto-Neto AM Menopause; 2015 Jul; 22(7):741-9. PubMed ID: 25423326 [TBL] [Abstract][Full Text] [Related]
51. Decreased bone resorption with soy isoflavone supplementation in postmenopausal women. Harkness LS; Fiedler K; Sehgal AR; Oravec D; Lerner E J Womens Health (Larchmt); 2004 Nov; 13(9):1000-7. PubMed ID: 15665657 [TBL] [Abstract][Full Text] [Related]
52. Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. Setchell KD; Brown NM; Desai P; Zimmer-Nechemias L; Wolfe BE; Brashear WT; Kirschner AS; Cassidy A; Heubi JE J Nutr; 2001 Apr; 131(4 Suppl):1362S-75S. PubMed ID: 11285356 [TBL] [Abstract][Full Text] [Related]
53. A randomised double-blind controlled trial of oral soy supplements versus placebo for treatment of menopausal symptoms in patients with early breast cancer. MacGregor CA; Canney PA; Patterson G; McDonald R; Paul J Eur J Cancer; 2005 Mar; 41(5):708-14. PubMed ID: 15763646 [TBL] [Abstract][Full Text] [Related]
54. Effect of consumption of soy isoflavones on behavioural, somatic and affective symptoms in women with premenstrual syndrome. Bryant M; Cassidy A; Hill C; Powell J; Talbot D; Dye L Br J Nutr; 2005 May; 93(5):731-9. PubMed ID: 15975174 [TBL] [Abstract][Full Text] [Related]
55. Phytoestrogens and breast cancer in postmenopausal women: a case control study. Murkies A; Dalais FS; Briganti EM; Burger HG; Healy DL; Wahlqvist ML; Davis SR Menopause; 2000; 7(5):289-96. PubMed ID: 10993028 [TBL] [Abstract][Full Text] [Related]
56. Comparison of plasma and urinary phytoestrogens in Japanese and Finnish women by time-resolved fluoroimmunoassay. Uehar M; Arai Y; Watanabe S; Adlercreutz H Biofactors; 2000; 12(1-4):217-25. PubMed ID: 11216489 [TBL] [Abstract][Full Text] [Related]
57. Soy protein and isoflavone effects on vasomotor symptoms in peri- and postmenopausal women: the Soy Estrogen Alternative Study. Burke GL; Legault C; Anthony M; Bland DR; Morgan TM; Naughton MJ; Leggett K; Washburn SA; Vitolins MZ Menopause; 2003; 10(2):147-53. PubMed ID: 12627040 [TBL] [Abstract][Full Text] [Related]
58. Long-term soy isoflavone supplementation and cognition in women: a randomized, controlled trial. Henderson VW; St John JA; Hodis HN; Kono N; McCleary CA; Franke AA; Mack WJ; Neurology; 2012 Jun; 78(23):1841-8. PubMed ID: 22665144 [TBL] [Abstract][Full Text] [Related]
59. Phytoestrogens and the menopause. Eden J Baillieres Clin Endocrinol Metab; 1998 Dec; 12(4):581-7. PubMed ID: 10384814 [TBL] [Abstract][Full Text] [Related]